GoodRx Holdings, Inc. (GDRX) stock
GDRXNasdaqServices-Computer Processing & Data PreparationFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 11/3037% below fair value
$3.47−0.04 (-1.14%)
Close on Nov 17, 2026Market cap $1.18BP/E 86.8Yield –
GoodRx price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
GoodRx's price to sales ratio was 1.6× on Nov 11, 2026, against 1.3× a year earlier. Over the last 5 years it ranged from 0.8× to 19.5×, with a median of 2.7×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.6× | +0.4 |
| 2025 | Dec 31, 2025 | 1.2× | −1.0 |
| 2024 | Dec 31, 2024 | 2.3× | −1.5 |
| 2023 | Dec 29, 2023 | 3.8× | +1.4 |
| 2022 | Dec 30, 2022 | 2.3× | −17.1 |
| 2021 | Dec 31, 2021 | 19.5× | +0.8 |
| 2020 | Dec 31, 2020 | 18.7× | – |
See a number that looks wrong?